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Previewsrules out transdifferentiation or fusion as
underlying mechanisms responsible for
the new cardiomyocytes seen at 8 weeks.
One remaining possibility is that the 20%
of cardiomyocytes in which the Cre
system failed to induce recombination is
somehow different from the other 80%,
e.g., in this population’s ability to re-enter
the cell cycle. The initial paper describing
this system found no differences in DNA
synthesis rates at selected times postin-
farction (Hsieh et al., 2007), but this
general caveat is worth keeping in mind.
The chemokine stromal-derived factor-
1 (SDF-1, a.k.a. CXCL12) is upregulated
in the infarcted heart and mediates
homing of marrow-derived c-kit+ cells
from the circulation. To assess whether
recruitment of circulating c-kit+ stem cells
could mimic effects of exogenous c-kit+
cells, a protease-resistant version of
SDF-1 was directly administered to the
infarcted heart. In previous studies, this
factor are increased recruitment of
CXCR4+/c-kit+ progenitor cells to the site
of administration and increasedmicrovas-
cular density (Segers et al., 2007). While
SDF-1 administration did recapitulate
increased vascularization, no enhance-
ment in derivation of cardiomyocytes
from progenitors was seen.
A good experiment often opens up
more questions than it answers, and that352 Cell Stem Cell 8, April 8, 2011 ª2011 Elsis the case with this study from Loffredo
et al. What are the cardiomyocyte progen-
itor cells? The genetic system provides
strong evidence for their function, but it
cannot identify them. These candidate
stem cells are clearly not the transplanted
c-kit+ cells from bone marrow, and
the authors’ transplantation studies do
not favor either resident cardiac c-kit+
cells (because transplanted resident
cardiac c-kit+ cells did not survive to
form new cardiomyocytes) or marrow-
derived MSCs. Perhaps the activity
resides within perivascular Sca1+ cell,
the Hoechst dye-effluxing side popula-
tion, or something beyond the list of usual
suspects. Another important question
is how do marrow-derived c-kit+ cells
exert their effects, and is this mechanism
a normal component of the inflammatory
response to infarction that is revealed by
cell transplantation? If we can identify
these paracrine signals, perhaps we can
control their responses without resorting
to cell therapy. Despite these open ques-
tions, the study by Loffredo et al. helps
elucidate the role of bonemarrow-derived
c-kit+ cells to expand the endogenous
cardiomyocyte population, and it demon-
strates, excitingly, that this endogenous
population can be manipulated and
enriched. Thus, we are brought a step
closer to one of the most exciting newevier Inc.therapeutics in the field of cardiovascular
medicine.
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Growing evidence shows that stem cells are modulated by systemic factors that are integrated with local
signals in response to physiological status. Two recentCell (Chell and Brand, 2010) andNature (Sousa-Nunes
et al., 2011) papers reveal that Drosophila neural stem cell proliferation is controlled by a diet-dependent
insulin/TOR signaling relay between tissues.Despite intensive research on stem cells,
a largely unanswered question is how
the behavior of these key cell populationsis influenced by the physiological state
of the organism. Studies using adult
Drosophila stem cells have shed somelight on this question and reveal para-
digms that may be applicable to mamma-
lian systems. Several groups, including
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Figure 1. Dietary Stem Cell Regulation in Drosophila
(A) In larvae, fat body TOR-mediated amino acid sensing
induces a secreted fat body-derived signal (FDS) that acti-
vates glial insulin-like peptide (ILP) expression. Glial ILPs act
on adjacent neuroblasts via insulin/PI3K/TOR signaling to
control reactivation. The same or another FDS activates
median neurosecretory cell (mNSC) ILP production.
(B) In adults, diet-dependent mNSC ILPs activate insulin/
PI3K signaling in intestinal stem cells (ISCs) and germline
stem cells (GSCs), and ILPs also affect the female GSC niche.
FDSs might have direct or indirect effects on other growing
tissues or adult stem cells. Solid lines, known signals; dashed
lines, hypothetical relays.
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Previewsthose of Leanne Jones, Yoshihiro
Inoue, and our own, have shown
that Drosophila germline stem cells
(GSCs) and intestinal stem cells
(ISCs) respond to diet via systemic
insulin-like peptides (ILPs; LaFever
and Drummond-Barbosa, 2005;
reviewed in Jasper and Jones,
2010). For example, in adult
females, ILPs directly alter GSCdivi-
sion rates and indirectly control
GSC maintenance by modulating
Notch signaling and E-cadherin in
the niche (Hsu and Drummond-
Barbosa, 2009; LaFever and Drum-
mond-Barbosa, 2005). Although
effects of diet and insulin signaling
on larval germ cell precursors have
been reported in other systems
(reviewed in Narbonne and Roy,
2006), much less is known mecha-
nistically about how diet regulates
the balance between proliferation
and quiescence of stem cells during
development.
In the developing Drosophila
central nervous system (CNS), stem
cells called neuroblasts undergo
embryonic and larval proliferation
phases separated by a quiescent
state that is reversed by dietary
amino acids (Britton and Edgar,
1998). Althoughorganculture exper-
iments had previously implicated
a humoral factor from the liver- and
adipose tissue-like fat body (Britton
and Edgar, 1998), the molecular
and cellular mechanisms regulating
the diet-dependent neuroblast exit
from quiescence, or reactivation, re-
mained unknown. Now, recent
studies (Chell and Brand, 2010;
Sousa-Nunes et al., 2011) demon-
strate that a diet-induced, fat
body-derived signal controls ILPproduction in glial cells, thereby activating
growth and proliferation of neighboring
neuroblasts.
Gould and colleagues found that block-
ing fat body vesicular trafficking disrupts
neuroblast reactivation, demonstrating
an in vivo requirement for a fat body-
secreted factor (Sousa-Nunes et al.,
2011). Because fat body cells promote
organismal growth via a factor secreted
downstream of the amino acid transporter
Slimfast (Slif) and Target of rapamycin
(TOR) signaling (Colombani et al., 2003),
they tested whether a similar mechanismcontrols neuroblast reactivation. Indeed,
neuroblasts were unable to exit quies-
cence upon global TOR inactivation
or fat body-specific inhibition of Slif or
TOR (Sousa-Nunes et al., 2011). The fat
body signal identity, however, remains
unknown.
In mammals, proliferation of neural
stem cells requires insulin-like growth
factor (reviewed in D’Ercole and Ye,
2008). Likewise, the Brand and Gould
laboratories found that simultaneous
elimination of several Drosophila ILPs in
global mutants abrogates neuroblastCell Stem Cell 8,reactivation (Chell and Brand,
2010; Sousa-Nunes et al., 2011). In
accordance, reactivating neuro-
blasts show increased levels of
a phosphoinositide-3-kinase (PI3K)
reporter, suggestive of active insulin
signaling (Chell and Brand, 2010).
Both groups showed an intrinsic
neuroblast requirement for insulin/
PI3K/TOR signaling because ex-
pression of inhibitory transgenes
blocking insulin/PI3K/TOR specifi-
cally in neuroblasts blocked their
reactivation. Conversely, forced
activation of insulin/PI3K/TOR sig-
naling in neuroblasts was sufficient
to promote exit from quiescence in
nutrient-deprived larvae or in ex-
planted CNS cultured without fat
bodies (Chell and Brand, 2010;
Sousa-Nunes et al., 2011). These
results indicate that ILPs act directly
on neuroblasts to induce reactiva-
tion, although direct sensing of nutri-
ents by neuroblasts via TOR might
also occur.
What is thesourceof ILPs?Median
neurosecretory cells (mNSCs) in
the brain secrete systemic ILPs
that control adult GSCs and ISCs
(LaFever and Drummond-Barbosa,
2005; also see Jasper and Jones,
2010). During larval stages, the
fat body remotely controls diet-
dependent release of ILPs from
mNSCs via a systemic signal
to promote organismal growth
(Colombani et al., 2003; Geminard
et al., 2009). Intriguingly, however,
although mNSC ILP overexpression
or increased mNSC size or secretion
leads to larger body size, similar
genetic manipulations have no effect
on neuroblast reactivation, suggest-
ing that neuroblasts do not respondto mNSC-derived ILPs (Sousa-Nunes
et al., 2011). Instead, glial cells that
envelop neuroblasts produce multiple
ILPs in a diet-dependent manner during
neuroblast reactivation (Chell and Brand,
2010; Sousa-Nunes et al., 2011). Further,
glial or neuronal ILP overexpression is
sufficient to reactivate quiescent neuro-
blasts under low nutrients, whereas
inhibition of vesicular trafficking in glia
blocks neuroblast reactivation, in both
cases with no consequence to organismal
growth (Chell and Brand, 2010; Sousa-
Nunes et al., 2011). These data supportApril 8, 2011 ª2011 Elsevier Inc. 353
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Previewsa model wherein the fat body senses die-
tary factors (e.g., amino acids) via Slif/
TOR signaling, and secretes a systemic
signal(s) to both mNSCs and glia that
increases circulating and local ILP levels,
respectively. Systemic ILPs promote
organismal growth (and adult GSC and
ISC activity), while local glial ILPs act
directly on neuroblasts to promote
reactivation.
Why are neuroblasts unresponsive to
systemic ILPs (e.g., in contrast to adult
GSCs and ISCs)? Gould and colleagues
speculate that the CNS neuroblasts might
be physically isolated from systemic ILPs
by the blood brain barrier, thus requiring
a local source of ILPs (Sousa-Nunes
et al., 2011). It is conceivable, however,
that other stem cells might also respond
to local ILPs, considering that multiple
tissues express functionally redundant
ILPs. In this scenario, differences in ILP
source between stem cell populations
might simply reflect a varying requirement
for high local concentrations of ILPs ac-
cording to insulin signaling response
thresholds.
These findings represent the ‘‘tip of the
iceberg’’ for what is likely a complex and
sophisticated physiological network
impinging on stem cells in response to
dietary fluctuations (Figure 1). The fat
body is emerging as a central player in354 Cell Stem Cell 8, April 8, 2011 ª2011 Elsthis network, in remarkable parallel to
the mammalian adipose tissue, which
has major endocrine roles. Given that
distinct populations of ILP-producing
cells (i.e., glia and mNSCs) are modulated
by diet-dependent, fat body-derived
systemic signals, it is possible that
different factors might target each popu-
lation. Such systemic signals might also
control additional local signals or act
directly on stem cells in different tissues.
Multiple fat body signals—possibly
a combination of signaling lipids and/or
peptide hormones, as for the mammalian
adipose tissue—would allow the fat body
to coordinate rapid stem cell-specific
responses to different types of dietary
fluctuations.
Finally, the question of how diet and
other physiology-altering factors (such
as aging, stress, injury, or infection)
impact stem cell populations is highly
relevant to our understanding of stem
cell biology in general (reviewed in Drum-
mond-Barbosa, 2008). As recent studies
exemplify (Chell and Brand, 2010;
Sousa-Nunes et al., 2011; Hsu and Drum-
mond-Barbosa, 2009), the answer to this
multilayered question lies not only in iden-
tifying the organs/tissues/cells and
respective systemic factors involved in
modulating various stem cell populations,
but also in elucidating how these humoralevier Inc.signals are integrated with each other and
with local and intrinsic factors to control
stem cell behavior.REFERENCES
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Selective targeting of cancer stem cells (CSCs) has the potential to prevent cancer relapse. Wang et al. (2011)
report that hypoxia-inducible factor 1a (HIF1a) represses Notch signaling to maintain CSC subsets from
lymphoma, and that blocking HIF1a activity eliminates lymphoma and human acute myeloid leukemia
(AML) CSCs.The cancer stem cell hypothesis posits
that CSCs are a subpopulation present
within a tumor that undergoes self-re-newal to drive tumorigenesis when serially
transplanted into recipients and, in doing
so, differentiate into the heterogeneouscell types that characterize the tumor of
origin (Wicha et al., 2006). The first evi-
dence supporting the concept of CSCs
